Skip to content
Search

Latest Stories

PSNC calls for price concession fix as system is no longer working for pharmacy contractors

The Pharmaceutical Services Negotiating Committee (PSNC)’s members are seeking immediate rescue packages for the sector to help with energy bills and to ease capacity constraints.

In a meeting held on 14th and 15th September, the committee members expressed their anger and frustration on the reluctance of NHS England and government to fund pharmacy sustainably.


The meeting was held to consider practical steps to ease the pressures on the community pharmacy sector, and to oversee the progress of negotiations on the Community Pharmacy Contractual Framework (CPCF) and other work.

Committee members, as pharmacy contractors, shared their experiences of the current pressures on all contractors, including the inability to deliver some services and to maintain core service levels; the capacity and workforce crises facing the sector; the critical need for funding support this winter; and the urgent need for Government to adapt the Price Concessions system to meet the needs of contractors.

The Price Concessions system is no longer working for contractors in the current volatile medicine supply environment and PSNC is clear this is not acceptable,” said the committee.

“We have sent a strong and clear message back to Government that pharmacies cannot subsidise the NHS medicines bill, escalating this within the Department of Health and Social Care (DHSC) and insisting that they find urgent solutions.”

Over the reluctance of NHS England and Government to fund pharmacy sustainably, PSNC said, it ‘will lead the sector in holding them to account for this, including through the work to develop a new vision and strategy for the community pharmacy sector.’

A deal on Year 4 of the five-year CPCF was agreed in principle over the summer but is awaiting final cross-government approval following ministerial resignations in the summer.

The committee reconsidered this in light of the rapidly worsening economic outlook for community pharmacies.

The Committee also considered funding delivery, looked at key service-related consultations, and made early decisions on PSNC’s Transforming Pharmacy Representation (TAPR) work.

As part of the TAPR work, they considered key questions about PSNC’s governance – ahead of a full governance review – and contractor levies, and these will be discussed at the upcoming LPC Conference before announcements are made to contractors.

At the LPC Conference in Manchester this week (September 22), PSNC members and LPCs came together to explore further practical solutions to the pressures facing contractors and to look at how local and national representatives can best collaborate on those.

Prior to the meeting, PSNC chief executive Janet Morrison said: “PSNC’s committee members, all of whom are community pharmacy contractors or representatives of contractors, have this month reflected the anger and frustration that is being felt across the sector.

Pharmacies stepped up during the pandemic to deliver all that the government and NHS needed, yet you are now struggling to keep afloat while those same two organisations allow Drug Tariff and concession price issues, spiralling costs, and other pressures to decimate your businesses. This is not acceptable to us, it is not acceptable to NHS patients, and it won’t be acceptable to the public: PSNC is clear that policy-makers must be held to account for it.

“We are continuing to take a very hard line on all of these issues, alongside ramping up our influencing and data-gathering work as we seek short-term solutions for all contractors. During the pandemic we and the wider the sector fought very hard for contractors’ Covid costs to be covered and that is what we will do again now, with energy prices, with Price Concessions, and with overall funding levels. Thank you once again to all those contractors who have contacted us about these issues and for all the evidence you provide on an ongoing basis – we will be needing more of this soon.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less